Butamirato Mylan Generics indications
Oral
Cough suppression
Adult: For dry non-productive cough: As 50 mg tab: 2 or 3 tabs 8-12 hrly. As 7.5 mg/5 mL syr: 15 mL 4 times daily.
Child: As 50 mg tab:
Butamirato Mylan Generics description
Each sustained-release film-coated tablet contains 50 mg of Butamirato Mylan Generics citrate. Each teaspoonful (5 mL) syrup contains 7.5 mg of Butamirato Mylan Generics citrate.
Butamirato Mylan Generics dosage
The maximum duration of treatment without doctor's prescription is one week.
Tablet: Adolescents Over 12 Years of Age: 1 or 2 tablets daily.
Adults: 2 or 3 tablets daily at 8 or 12 hour intervals. To be swallowed whole.
Syrup: Children 3 to 6 Years of Age: One teaspoonful (5 mL) 3 times daily.
Children 6 to 12 Years of Age: Two (2) teaspoonfuls (10 mL) 3 times daily.
Adolescents Over 12 Years of Age: One tablespoonful (15 mL) 3 times daily.
Adults: 15 mL 4 times daily.
Wash and dry the graduated cup after each use and between different users.
Butamirato Mylan Generics interactions
Sulphinpyrazone, a drug used as an antithrombotic agent and inhibitor of platelet aggregation has a potent side effect as a uricosuric agent. The uricosuric side effect increases the urinary excretion of uric acid effectively blocking hepatic conjugation. Tests show that Sulphinpyrazone’s effect on Butamirato Mylan Generics is a reduction of liver function to 60% of normal without interfering with protein binding. Taking alpha-lipoic acid or chromium with tolbutamide may require a change in the drugs dosage. Use ephedra with caution when taking tolbutamide; ephedra can raise blood sugar levels.
Butamirato Mylan Generics side effects
Adverse reactions are listed by system organ class and frequency. Frequencies are defined as: Very common (=1/10); common (=1/100 to <1/10); uncommon (=1/1,000 to <1/100); rare (=1/10,000 to <1/1,000); very rare (<1/10,000), or not known (cannot to be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Nervous System Disorders: Rare: Somnolence.
Gastrointestinal Disorders: Rare: Nausea, diarrhea.
Skin and Subcutaneous Tissue Disorders: Rare: Urticaria.
Butamirato Mylan Generics contraindications
You should not take tolbutamide if you have had an allergic reaction to it. Butamirato Mylan Generics should not be taken if you are suffering from diabetic ketoacidosis (a life-threatening medical emergency caused by insufficient insulin and marked by excessive thirst, nausea, fatigue, pain below the breastbone, and fruity breath). In addition, Butamirato Mylan Generics should not be used as the sole therapy in treating type 1 (insulin-dependent) diabetes.
Active ingredient matches for Butamirato Mylan Generics:
Butamirate in Italy.
List of Butamirato Mylan Generics substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Butamirate Norma (Greece) | |
| Butaxin 5 | |
| Butiran (Italy) | |
| Butirol (Turkey) | |
| Butirol Fort (Turkey) | |
| Butrin (Greece) | |
| Buvastin (Greece) | |
| Chemisolv (Greece) | |
| Chributan (Greece) | |
| Codactiv (Turkey) | |
| Codactiv Fort (Turkey) | |
| Codexine-R (Greece) | |
| Codimin (Greece) | |
| Cofmed (Philippines) | |
| Cofmed SR tab 50 mg 40's (Medhaus) | |
| Cofmed syr 7.5 mg/5 mL 60 mL x 1's (Medhaus) | |
| Cough Cut (Egypt) | |
| Cutmirat (Turkey) | |
| Cyne (Greece) | |
| Deconil (Bangladesh) | |
| DemoTussol (Switzerland) | |
| Drops; Oral; Butamirate Citrate 22.5 mg / ml (Vifor) | |
| Syrup; Oral; Butamirate Citrate 22.5 mg / 15 ml (Vifor) | |
| Tablet; Oral; Butamirate Citrate 22.5 mg (Vifor) | |
| Devix (Greece) | |
| Doctamine (Greece) | |
| Dosodos (Argentina) | |
| Dricod (Tunisia) | |
| Drosten (Greece) | |
| Ellisek (Greece) | |
| Ellisek-S (Greece) | |
| Gertotus (Greece) | |
| Gertotuss (Greece) | |
| Icorin Kids (Thailand) | |
| Kofnix-SR (Bangladesh) | |
| Kreval (Turkey) | |
| Kreval Forte (Turkey) | |
| Kreval Plus (Turkey) | |
| Leogumil (Greece) | |
| Lexosedin (Italy) | |
| Lexosedin Butamirato Mylan Generics (Italy) | |
| Mebronol (Greece) | |
| Mera (Bangladesh) | |
| Minatuss (Greece) | |
See 164 substitutes for Butamirato Mylan Generics | |
Reviews
The results of a survey conducted on ndrugs.com for Butamirato Mylan Generics are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Butamirato Mylan Generics. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
